Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.00B.
ENTERPRISE VALUE (EV)
$1.00B
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.10B
Enterprise Value (EV)
$1.00B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.10B | $1.00B |
| IRadimed Corporation (IRMD)vs › | $1.09B | $1.03B |
| Replimune Group, Inc. (REPL)vs › | $1.11B | $1.04B |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.06B | $988.19M |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | $1.60B |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | $1.32B |
| Harrow Health, Inc. (HROW)vs › | $1.14B | $1.36B |
| OPKO Health, Inc. (OPK)vs › | $1.14B | $1.23B |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | $1.04B |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | $1.02B |
Market Cap
$1.10B
Total Debt
$0.00
Cash
$96.69M
Enterprise Value
$1.00B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
